Sildenafil N-oxide as prodrug

Details for Australian Patent Application No. 2008267274 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Turski, Lechoslaw A.; Kruse, Cornelis G.; Tulp, Martinus; Vader, Sander; Stoit, Axel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008267274

PCT Pub. Number WO2009/000798

Priority 07111030.8 26.06.07 EP; 60/946,198 26.06.07 US

Filing date 23 June 2008

Wipo publication date 31 December 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 15/10 (2006.01) Drugs for genital or sexual disorders

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/000798 Priority application(s): WO2009/000798

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008267279-Novel prebiotics

2008267273-N-oxides of venlafaxine and Odesmethylvenlafaxine as prodrugs